EP1043963A4 - Osteopontin-based compositions for enhancing bone repair - Google Patents

Osteopontin-based compositions for enhancing bone repair

Info

Publication number
EP1043963A4
EP1043963A4 EP19980965015 EP98965015A EP1043963A4 EP 1043963 A4 EP1043963 A4 EP 1043963A4 EP 19980965015 EP19980965015 EP 19980965015 EP 98965015 A EP98965015 A EP 98965015A EP 1043963 A4 EP1043963 A4 EP 1043963A4
Authority
EP
Grant status
Application
Patent type
Prior art keywords
osteopontin
based compositions
bone repair
enhancing bone
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19980965015
Other languages
German (de)
French (fr)
Other versions
EP1043963A1 (en )
Inventor
Dale R Peterson
Nancy Nousek-Goebl
Todd P Glancy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Orthopaedics Inc
Original Assignee
DePuy Orthopaedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00365Proteins; Polypeptides; Degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures
EP19980965015 1997-12-31 1998-12-30 Osteopontin-based compositions for enhancing bone repair Withdrawn EP1043963A4 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US7024697 true 1997-12-31 1997-12-31
US70246P 1997-12-31
PCT/US1998/027808 WO1999033415A1 (en) 1997-12-31 1998-12-30 Osteopontin-based compositions for enhancing bone repair

Publications (2)

Publication Number Publication Date
EP1043963A1 true EP1043963A1 (en) 2000-10-18
EP1043963A4 true true EP1043963A4 (en) 2001-02-07

Family

ID=22094102

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19980965015 Withdrawn EP1043963A4 (en) 1997-12-31 1998-12-30 Osteopontin-based compositions for enhancing bone repair

Country Status (3)

Country Link
EP (1) EP1043963A4 (en)
JP (1) JP2001527030A (en)
WO (1) WO1999033415A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19957388A1 (en) 1999-11-24 2001-06-13 Michael Sittinger Chondroinductive and Implantable substrates for cartilage healing and -protektion
US20020048577A1 (en) * 2000-08-01 2002-04-25 University Of Washington Methods and devices to modulate the wound response
EP1328286B2 (en) * 2000-10-05 2012-10-31 New Zealand Dairy Board Bone health compositions derived from acidic whey
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7767221B2 (en) 2004-03-05 2010-08-03 The Trustees Of Columbia University In The City Of New York Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue to bone
WO2007068252A3 (en) * 2005-12-16 2007-08-30 Arla Foods Amba Bovine osteopontin formulations for the improvement of the wound healing process
US8753391B2 (en) 2007-02-12 2014-06-17 The Trustees Of Columbia University In The City Of New York Fully synthetic implantable multi-phased scaffold
DK2681230T3 (en) 2011-03-03 2016-03-21 Arla Foods Amba A method for isolating osteopontin BY APPLICATION OF RAW MATERIALS CONTAINING CASEINOMAKROPEPTID (CMP)
WO2016179089A1 (en) * 2015-05-01 2016-11-10 Rensselaer Polytechnic Institute Biomimetic nano-composite scaffold for enhanced bone healing and fracture repair

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035000A1 (en) * 1996-03-18 1997-09-25 The Trustees Of The University Of Pennsylvania Bioactive material substrate for enhanced cellular attachment and function
WO1997041842A1 (en) * 1996-05-09 1997-11-13 The Trustees Of The University Of Pennsylvania Hollow bone mineral-like calcium phosphate particles
WO1998014222A1 (en) * 1996-09-30 1998-04-09 Children's Medical Center Corporation Methods and compositions for programming an organic matrix for remodeling into a target tissue

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
DE69418865D1 (en) * 1993-03-29 1999-07-08 Zymogenetics Inc Osteoblastswachstumfordernde compositions of the PDGF and vitamin D contained
US5372503A (en) * 1993-04-27 1994-12-13 Dental Marketing Specialists, Inc. Method for installation of a dental implant
US5824651A (en) * 1993-05-10 1998-10-20 Universite De Montreal Process for modification of implant surface with bioactive conjugates for improved integration

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035000A1 (en) * 1996-03-18 1997-09-25 The Trustees Of The University Of Pennsylvania Bioactive material substrate for enhanced cellular attachment and function
WO1997041842A1 (en) * 1996-05-09 1997-11-13 The Trustees Of The University Of Pennsylvania Hollow bone mineral-like calcium phosphate particles
WO1998014222A1 (en) * 1996-09-30 1998-04-09 Children's Medical Center Corporation Methods and compositions for programming an organic matrix for remodeling into a target tissue

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9933415A1 *

Also Published As

Publication number Publication date Type
EP1043963A1 (en) 2000-10-18 application
WO1999033415A1 (en) 1999-07-08 application
JP2001527030A (en) 2001-12-25 application

Similar Documents

Publication Publication Date Title
GB9826555D0 (en) Microemulsion compositions
GB9806594D0 (en) Microemulsion compositions
GB9824450D0 (en) Malodour counteractant compositions
GB9621436D0 (en) Enzymatic compositions
GB9415885D0 (en) Organosiloxane compositions
GB9415842D0 (en) Organosiloxane compositions
GB2314014B (en) Closure-arrangements for loose-covers
GB2329836B (en) Mouthwash compositions
GB9405006D0 (en) Compositions for can ends
GB9818910D0 (en) Novel formulation
GB9810180D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation
GB2338650B (en) A thixotropic composition for use as a spray
GB9726896D0 (en) Solid detergent compositions
GB9828488D0 (en) Detergent compositions
GB9823695D0 (en) Detergent compositions
GB9822090D0 (en) Detergent Compositions
GB9803770D0 (en) Detergent compositions
GB9826097D0 (en) Detergent compositions
GB9806294D0 (en) Detergent compositions
GB9824358D0 (en) Detergent compositions
GB9826105D0 (en) Detergent compositions
GB9827225D0 (en) Detergent compositions
GB9804714D0 (en) Detergent compositions
GB9817282D0 (en) Detergent compositions

Legal Events

Date Code Title Description
17P Request for examination filed

Effective date: 20000726

AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): CH DE FR GB IE IT LI

A4 Despatch of supplementary search report

Effective date: 20001227

AK Designated contracting states:

Kind code of ref document: A4

Designated state(s): CH DE FR GB IE IT LI

RIC1 Classification (correction)

Free format text: 7A 61F 2/28 A, 7A 61L 27/00 B, 7C 07K 14/52 B

17Q First examination report

Effective date: 20030225

18D Deemed to be withdrawn

Effective date: 20040629